Evolus to Report Fourth Quarter and Year End 2022 Results and Provide Business Update
23 February 2023 - 12:45AM
Business Wire
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
customer-centric approach focused on delivering breakthrough
products, today announced that it will report its fourth quarter
and year end 2022 financial results and provide a business update
on Wednesday, March 8, 2023, after the U.S. financial markets
close.
Evolus management will host a conference call and live webcast
to discuss these results at 4:30 p.m. ET that same day. A
question-and-answer session will follow management’s remarks.
To participate in the conference call, dial (877) 407-6184
(U.S.) or (201) 389-0877 (international) or connect to the live
webcast via the link on the Investor Relations page of the Evolus
website at www.evolus.com.
Following the completion of the call, a telephonic replay can be
accessed by dialing (877) 660-6853 (U.S.) or (201) 612-7415
(international) and using conference number 13736592. An archived
webcast can also be accessed on the Investor Relations page of the
Evolus website at www.evolus.com.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving
the aesthetic neurotoxin market for the next generation of beauty
consumers through its unique, customer-centric business model and
innovative digital platform. Our mission is to become a global,
multi-product aesthetics company based on our flagship product,
Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin
dedicated exclusively to aesthetics and manufactured in a
state-of-the-art facility using Hi-Pure™ technology. Visit us at
www.evolus.com and follow us on LinkedIn, Twitter, Instagram or
Facebook.
Jeuveau® is a registered trademark of Evolus, Inc. Hi-Pure™ is a
trademark of Daewoong Pharmaceutical Co, Ltd.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230222005270/en/
Investor/Media Contact: David K.
Erickson, Evolus, Inc. Vice President, Investor Relations Tel:
949-966-1798 Email: david.erickson@evolus.com
Media Contact: Email:
media@evolus.com
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From May 2023 to Jun 2023
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Jun 2022 to Jun 2023
